Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: Regulation by I2 imidazoline ligands in intact cells

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 637-643

  Gargalidis Moudanos, C ^a   Remaury, A ^a   Pizzinat, N ^a   Parini, A ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; IMIDAZOLINE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME REGULATION; GENE EXPRESSION REGULATION; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RABBIT;

EID: 0030935117     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.637     Document Type: Article

References (35)

1. Weyler, W., Y.-P. P. Hsu, and X. O. Breakefield. Biochemistry and genetics of monoamine oxidase. Pharmacol. Ther. 47:391-417 (1990).
2. Bach, A. W., N. C. Lan, D. L. Johnson, C. W. Abell, M. E. Bembenek, S. W. Kwan, P. H. Seeburg, and J. C. Shih. c-DNA cloning of human liver monoamine oxidase A and B. Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85:4934-4938 (1988).
3. Grimsby, J., K. Chen, L. J. Wang, N. C. Lan, and J. C. Shih. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc. Natl. Acad. Sci. USA 88:3637-3641 (1991).
4. Youdim, M. B. H., and J. P. M. Finberg. New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochem. Pharmacol. 41(2):155-162 (1991).
5. Yasuhara, H., S. H. Parvez, K. Oguchi, M. Sandler, and T. Nagatsu, eds. Monoamine Oxidase: Basic and Clinical Aspects. VSP, Utrecht, The Netherlands (1993).
6. Brunner, H. G., M. Nelen, X. O. Breakefield, H. H. Ropers, and B. A. van Oost. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science (Washington D. C.) 262:578-580 (1993).
7. Cases, O., I. Seif, J. Grimsby, P. Caspar, K. Chen, S. Pournin, U. Müller, M. Aguet, C. S. Babinet. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (Washington D. C.) 268:1763-1766 (1995).
8. Jarman, J., V. Glover, M. Sandler, N. Turjanski, and G. Stern. Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation. J. Neural. Transm. 5:1-4 (1993).
9. Singer, T. P., N. Castagnoli, Jr., R. R. Ramsay, and A. J. Trevor. Biochemical events in the development of Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 49:1-8 (1987).
10. Saura, J., J. M. Luque, A. M. Cesura, M. Da Prada, V. Chan-Palay, G. Huber, J. Löffler, and J. G. Richards. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62:15-30 (1994).
11. Sparks, D. L., V. M. Woeltz, and W. R. Markesbery. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch. Neurol. 48:718-721 (1991).
12. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270:9856-9861 (1995).
13. Raddatz, R., A. Parini, and S. M. Lanier. Imidazoline/guanidinium binding domains on monoamine oxidases: relationship to subtypes of imidazoline binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem. 270:27961-27968 (1995).
14. +. J. Pharmacol. Exp. Ther. 276:359-364 (1996).
15. 2 sites. J. Pharmacol. Exper. Ther. 272:681-688 (1995).
16. Fernandes, M. H., and P. Soares-da-Silva. Type A, B monoamine oxidase activities in the human and rat kidney. Acta. Physiol. Scand. 145:363-367 (1992).
17. Bello-Reuss, E. Effect of catecholamines on fluid reabsorption by the isolated proximal convoluted tubule. Am. J. Physiol. 238:F347-F352 (1980).
18. Siragy, H. M., R. A. Felder, N. L. Howel, R. L. Chevalier, M. J. Peach, and R. M. Carey. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am. J. Physiol. 257:F469-F477 (1989).
19. Itskowitz, H. D., Y. H. Chen, and C. Stier, Jr. Reciprocal renal effects of dopamine and 5-hydroxytryptamine formed within the rat kidney. Clin. Sci. 75:503-507 (1988).
20. Baines, A. D., and W. Chan. Production of urine free dopamine from dopa: a micropuncture study. Life Sci 26:253-259 (1980).
21. Lee, M. R. Dopamine and the kidney. Clin. Sci. 62:439-148 (1982).
22. Fernandes, M. H., and P. Soares-da-Silva. Role of monoamine oxidase A and B in the deamination of newly formed dopamine in the rat kidney. J. Neural. Transm. 32:155-159 (1990).
23. Poujeol, P., and A. Vandewalle. Phosphate uptake by proximal cells isolated from rabbit kidney: role of dexamethasone. Am. J. Physiol. 249: F461-F471 (1985).
24. Limon, I., I. Coupry, S. M. Lanier, and A. Parini. Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney. J. Biol. Chem. 267:21645-21649 (1992).
25. Lanier, S. M., B. Ivkovic, I. Singh, J. L. Neumeyer, and V. Bakthavachalam. Visualization of multiple imidazoline/guanidinium receptive sites. J. Biol. Chem. 268:16047-16051 (1993).
26. Lanier, B., R. Raddatz, V. Bakthavachalam, I. Coupry, J. L. Neumeyer, and S. M. Lanier. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mol. Pharmacol. 48:703-710 (1995).
27. + antiport activity in the rabbit renal proximal tubule. J. Clin. Invest. 80:1755-1762 (1987).
28. M. R. Lee. Dopamine and the kidney: ten years on. Clin. Sci. 84:357-375 (1993).
29. 2 receptors. Biochem. J. 312:433-437 (1995).
30. P. Soares-da-Silva. Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem. Pharmacol. 45:1791-1800 (1993).
31. Caramona, M. M., and P. Soares-da-Silva. Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:411-413 (1990).
32. Fernandes, M. H., and P. Soares-da-Silva. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J. Neural. Transm. 41:101-105 (1994).
33. 2 with monoamine oxidase-B sites. J. Neurochem. 61:881-889 (1993).
34. Sowers, J. R., M. B. Zemel, P. Zemel, F. W. J. Beck, M. F. Walsh, and E. T. Zawada. Salt sensitivity in Blacks: salt intake and natriuretic substances. Hypertension (Dallas) 12:485-490 (1988).
35. De Feo, M. L., A. L. Jadhav, and M. F. Lokhandwala. Dietary sodium intake and urinary dopamine and sodium excretion during the course of blood pressure development in Dahl rats sensitive and salt resistant rats. Clin. Exp. Hypertens. A 9:76-80 (1987).